![](https://investorshub.advfn.com/uicon/151711.png?cb=1597324669)
Saturday, June 02, 2012 10:47:19 AM
up Mar-16-2012 0.0048 to 0.0049
about sales no one buys a product like Mamoview until all the insurance company's sign on and procedures have been outlined and proven...
We are at that threshold right now I believe...Everything the company has done has been leading up to this moment.... In spite of the current share price I feel very lucky to be here..
This company is clearly positioning to take their fair share of this ever growing endoscopy market..
IMO
GLTL
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM